Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10933662 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL61438 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL61124 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL10936179 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL61326 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL10937740 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL9691206 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL10975952 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL60617 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL62048 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 825 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260026506-A1 | COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER | AFFIX LABS OY (FI) | 2026-01-29 | — | — | US | claimed |
| US-20250263633-A1 | CLEANING AGENT COMPOSITION AND CLEANING METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2025-08-21 | — | — | US | claimed |
| EP-4561349-A1 | COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER | Affix Labs Oy (FI) | 2025-06-04 | — | — | EP | claimed |
| US-11899020-B2 | Shotgun proteomic antigen identification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-02-13 | — | — | US | claimed |
| WO-2024023183-A1 | COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER | AFFIX LABS OY (FI) | 2024-02-01 | — | — | WO | claimed |
| US-20240000999-A1 | SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES | UNIV CALIFORNIA (US) | 2024-01-04 | — | — | US | claimed |
| EP-3684745-B1 | INLINE PROCESS TO MAKE ANTIFOULING AGENT CO-CATALYST FOR ETHYLENE OLIGOMERIZATION | SAUDI ARABIAN OIL CO (SA) | 2023-07-19 | — | — | EP | claimed |
| US-20230015534-A1 | ELECTROPLATING COMPOSITION AND METHOD FOR DEPOSITING A CHROMIUM COATING ON A SUBSTRATE | Atotech Deutschland GmbH & Co. KG (DE) | 2023-01-19 | — | — | US | claimed |
| EP-4077770-A1 | ELECTROPLATING COMPOSITION AND METHOD FOR DEPOSITING A CHROMIUM COATING ON A SUBSTRATE | Atotech Deutschland GmbH & Co. KG (DE) | 2022-10-26 | — | — | EP | claimed |
| US-20220280927-A1 | ANTIFOULING OLIGOMERIZATION CATALYST SYSTEMS | SAUDI ARABIAN OIL COMPANY (SA) | 2022-09-08 | — | — | US | claimed |
| EP-1608392-A2 | PAPANICOLAU STAINING PROCESS | Cytyc Corporation (US) | 2005-12-28 | — | — | EP | claimed |
| EP-0756633-B1 | METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA | INTEGRATED RES TECHNOLOGY LLC (US) | 2005-06-08 | — | — | EP | claimed |
| WO-2005007895-A1 | METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES | APPLERA CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20050009036-A1 | Methods and kits for obtaining nucleic acid from biological samples | APPLERA CORPORATION (US) | 2005-01-13 | — | — | US | claimed |
| WO-2004086945-A2 | PAPANICOLAU STAINING PROCESS | CYTYC CORPORATION (US) | 2004-10-14 | — | — | WO | claimed |
| US-20040191854-A1 | Papanicolau staining process | CYTYC CORPORATION | 2004-09-30 | — | — | US | claimed |
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| US-6004771-A | EXTRACTED MYCOBACTERIAL SAMPLE IS SUITABLE FOR DETECTION BY CULTURE AND AMPLIFICATION | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1999-12-21 | — | — | US | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| US-5658749-A | DECREASING THE BUOYANCY OF MICROORGANISMS CONTAINING MYCOLIC ACID-LIKE STRUCTURES IN THE OUTER MEMBRANE USING A SOLUTION OF AN SB-18-LIKE OR ROD-LIKE DETERGENT; AMPHOTERIC SURFACTANTS; MEDICAL DIAGNOSIS; CULTURES; AMPLIFICATION | CORNING CLINICAL LABORATORIES, INC. (US) | 1997-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026506-A1 | COMPOSITION FOR DISSOLVING AN OILY COMPOUND IN WATER | ACHE, CYP51A1, DNER | BBOX1 2324/4885HTT 4394/4885DNM1 1614/4885 |
| US-20220280927-A1 | ANTIFOULING OLIGOMERIZATION CATALYST SYSTEMS | PFAS, PUF60, AS3MT | BBOX1 2993/4885HTT 2524/4885DNM1 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.